Population pharmacokinetics/pharmacodynamics of anesthetics

被引:3
|
作者
Olofsen E. [1 ]
Dahan A. [1 ]
机构
[1] Department of Anesthesiology, Leiden University Medical Center, 2300 RC Leiden
关键词
Anesthetics; NONMEM; PK/PD modeling;
D O I
10.1208/aapsj070239
中图分类号
学科分类号
摘要
In this article we review how population pharmacokinetic/pharmacodynamic (PD) modeling has evolved in the specialty of anesthesiology, how anesthesiology benefited from the mixed-effects approach, and which features of modeling need careful attention. Key articles from the anesthesiology literature are selected to discuss the modeling of typical anesthesiological PD end points, such as level of consciousness and analgesia, interactions between hypnotics and analgesics, estimation with poor and sometimes rich data sets from populations of various sizes, covariate detection, covariances between random effects, and Bayesian forecasting. Copyright ©2003. All Rights Reserved.
引用
收藏
页码:E383 / E389
页数:6
相关论文
共 50 条
  • [41] Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
    Bouazza, Naim
    Treluyer, Jean-Marc
    Ottolenghi, Chris
    Urien, Saik
    Deschenes, Georges
    Ricquier, Daniel
    Niaudet, Patrick
    Chadefaux-Vekemans, Bernadette
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [42] An Application of Ito's Lemma in Population Pharmacokinetics and Pharmacodynamics
    Murali Ramanathan
    [J]. Pharmaceutical Research, 1999, 16 : 584 - 586
  • [43] Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic Steatohepatitis
    Tseng, Chih-Ming Leo
    Balic, Kemal
    Charlton, R. Will
    Margalit, Maya
    Mansbach, Hank
    Savic, Rada M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1323 - 1331
  • [44] Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients
    Ikawa, Kazuro
    Morikawa, Norifumi
    Ikeda, Kayo
    Miki, Mizuka
    Kobayashi, Masao
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (02) : 139 - 143
  • [45] Population pharmacokinetics/pharmacodynamics modeling: Parametric and nonparametric methods
    Jelliffe, R
    Schumitzky, A
    Van Guilder, M
    [J]. THERAPEUTIC DRUG MONITORING, 2000, 22 (03) : 354 - 365
  • [46] Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients
    Chung, Eun Kyoung
    Fleming, Megan R.
    Cheatham, S. Christian
    Kays, Michael B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2017, 51 (03) : 209 - 218
  • [47] Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology
    Zandvliet, Anthe S.
    Schellens, Jan H. M.
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (08) : 487 - 513
  • [48] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF THIOPENTAL - THE EFFECT OF AGE REVISITED
    STANSKI, DR
    MAITRE, PO
    [J]. ANESTHESIOLOGY, 1990, 72 (03) : 412 - 422
  • [49] Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients
    Triggs, EJ
    Charles, BG
    Contin, M
    Martinelli, P
    Cortelli, P
    Riva, R
    Albani, F
    Baruzzi, A
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) : 59 - 67
  • [50] Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population
    Chen, Bing
    Shi, Hao-Qiang
    Feng, Meihua Rose
    Wang, Xi-Han
    Cao, Xiao-Mei
    Cai, Wei-Min
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13